Daratumumab plus lenalidomide and dexamethasone for untreated myeloma
- Submitting institution
-
University of Wolverhampton
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 1330
- Type
- D - Journal article
- DOI
-
10.1056/NEJMoa1817249
- Title of journal
- New England Journal of Medicine
- Article number
- -
- First page
- 2104
- Volume
- 380
- Issue
- 22
- ISSN
- 0028-4793
- Open access status
- Deposit exception
- Month of publication
- May
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
29
- Research group(s)
-
-
- Citation count
- 226
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to the organisation of the conduct of the study and to carrying out the study. The author helped draft the output and critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -